ViaGen provides state-of-the-art advanced breeding services powered by genomics to all sectors of the $240 billion livestock, aquaculture and companion animal industry. Unmatched genomic capabilities allow ViaGen to identify economically important genetic traits in virtually any animal species, information that is paired with ViaGen’s expertise in advanced reproductive technologies to obtain revenue enhancing improvements in quality, yield, safety and brand integrity. ViaGen is an Exeter Life Sciences company located in Austin, Texas. Exeter Life Sciences is a world leader in innovative health and life-sciences products and services that improve the lives of people, animals and the environment.

ViaGen was founded in Austin, Texas in January 2002 to provide commercial bovine, equine, and porcine gene banking, cloning, and genomics services. The cloning technologies we use were developed in part by scientists at Texas A&M University.

In 2003, ViaGen acquired ProLinia of Athens, Georgia. This acquisition doubled our cloning capacity, gave us the ability to produce clones from cells obtained from carcasses, and provided rights to cloning technologies developed by the Roslin Institute of Edinburgh, Scotland.